Formosa Laboratories Inc (4746)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Formosa Laboratories Inc (4746) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013933
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Formosa Laboratories Inc (Formosa) is a healthcare products provider that develops ingredients. The company develops and markets active pharmaceutical ingredients and UV filters. Its active pharmaceutical ingredients comprise anticancers, cholesterol and phosphate binders, MRI enhancing agents, CNS agents, immunomodulators, anti-inflammatory and analgesic agents, respiratory agents, steroids, and other products. Formosa offers UV filters which include avobenzone, phenylbenzimidazole sulfonic acid used in sunscreens and cosmetics. The company also offers contract research and custom synthesis services such as process development, route optimization, purity assessment, analytical support and commercial production. Formosa is headquartered in Taoyuan, Taiwan.

Formosa Laboratories Inc (4746) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Formosa Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Formosa Labs to Form Joint Venture with YungShin Global and Sichuan Neijiang Huixin Pharma 10
Equity Offering 11
Formosa Labs Completes Public Offering Of Common Stock For US$1.67 Million 11
Formosa Labs Completes Rights Offering Of Common Stock For US$12.5 Million 12
Formosa Labs Raises Funds in IPO 13
Formosa Labs Completes Public Offering Of Common Stock For US$16 Million 14
Debt Offering 15
Formosa Labs to Raise up to USD16.5 Million in Public Offering of Bonds Due 2017 15
Formosa Labs Announces Public Offeiring Of Notes Due 2015 For US$16.8 Million 16
Acquisition 17
Formosa Labs to Acquire Activus Pharma from Sosei Group 17
Formosa Laboratories Inc – Key Competitors 18
Formosa Laboratories Inc – Key Employees 19
Formosa Laboratories Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Formosa Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Formosa Laboratories Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Formosa Labs to Form Joint Venture with YungShin Global and Sichuan Neijiang Huixin Pharma 10
Formosa Labs Completes Public Offering Of Common Stock For US$1.67 Million 11
Formosa Labs Completes Rights Offering Of Common Stock For US$12.5 Million 12
Formosa Labs Raises Funds in IPO 13
Formosa Labs Completes Public Offering Of Common Stock For US$16 Million 14
Formosa Labs to Raise up to USD16.5 Million in Public Offering of Bonds Due 2017 15
Formosa Labs Announces Public Offeiring Of Notes Due 2015 For US$16.8 Million 16
Formosa Labs to Acquire Activus Pharma from Sosei Group 17
Formosa Laboratories Inc, Key Competitors 18
Formosa Laboratories Inc, Key Employees 19

★海外企業調査レポート[Formosa Laboratories Inc (4746)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • African Development Bank Group:電力:M&Aディール及び事業提携情報
    Summary African Development Bank Group (AfDB) is a development finance institution. It promotes social and economic development by providing loans, grants, guarantees, equity investments and technical assistance in its regional member countries. The constituent institutions of the bank include The A …
  • InKemia IUCT Group SA (IKM):製薬・医療:M&Aディール及び事業提携情報
    Summary InKemia IUCT Group SA (InKemia IUCT), formerly Institut Univ De Ciencia i Technology SA, is a biotechnology company. The company provides research and development, technological, and consulting services. It offers customized research services. InKemia IUCT provides technology services such a …
  • Telus Corp (T):企業の財務・戦略的SWOT分析
    Telus Corp (T) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • S. Kumars Nationwide Ltd:企業の戦略・SWOT・財務情報
    S. Kumars Nationwide Ltd - Strategy, SWOT and Corporate Finance Report Summary S. Kumars Nationwide Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • TaiDoc Technology Corporation (4736):企業の財務・戦略的SWOT分析
    TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • W.W. Grainger Inc (GWW):企業の財務・戦略的SWOT分析
    W.W. Grainger Inc (GWW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Europ Assistance Holding SA:企業の戦略的SWOT分析
    Europ Assistance Holding SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析
    Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • InterSystems Corp:企業の戦略的SWOT分析
    InterSystems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Cabela’s Incorporated:企業の戦略・SWOT・財務情報
    Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report Summary Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ELITechGroup Inc:企業の製品パイプライン分析2018
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cystic fibrosis, hematology, microbiology and molecular diagnostics. Its clinical chemistry produ …
  • Konecranes Plc:企業の戦略・SWOT・財務分析
    Konecranes Plc - Strategy, SWOT and Corporate Finance Report Summary Konecranes Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ANGLE Plc (AGL):製薬・医療:M&Aディール及び事業提携情報
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • Joincare Pharmaceutical Group Industry Co Ltd (600380):製薬・医療:M&Aディール及び事業提携情報
    Summary Joincare Pharmaceutical Group Industry Co Ltd (Joincare Pharma) is a manufacturer and supplier of pharmaceutical products. The company offers healthcare products, bulk prescription products, active pharmaceutical ingredients, OTC products, detection reagents, and food additives. Its healthca …
  • Noble Corporation Plc (NE):企業の財務・戦略的SWOT分析
    Noble Corporation Plc (NE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Krung Thai Bank PCL:企業の戦略・SWOT・財務分析
    Krung Thai Bank PCL - Strategy, SWOT and Corporate Finance Report Summary Krung Thai Bank PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Biowa Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biowa Inc (BioWa), a subsidiary of Kyowa Hakko Kirin Co Ltd (KHK), is a science and technology company that provides out licensing of therapeutic antibody technologies of KHK. The company also developes fucose free monoclonal antibodies that increase cellular cytotoxicity. Its technology inc …
  • Investigator Resources Ltd (IVR):企業の財務・戦略的SWOT分析
    Summary Investigator Resources Ltd (Investigator Resources), is a mining company that offers exploration and development of mineral properties. The company acquires, explores and develops precious and base metal assets in Eyre Peninsulas of South Australia. It operates projects such as Paris Silver …
  • NII Holdings, Inc.:企業の戦略・SWOT・財務情報
    NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vale Canada Ltd:企業の戦略・SWOT・財務情報
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆